Issue #299
- Efavirenz (Sustiva (tm)) May Equal or Exceed Protease Inhibitor in Initial Antiretroviral Combination
- Viral Resistance Overview
- Fusion inhibitors, T-20; Chemokine Variants; Tat and Interferon Antibodies: Gallo Describes Three New Treatment Approache
- Geneva Conference: Finding Information on the Web and Elsewhere
- AIDS Diarrhea: Phase III Trial Recruiting in Over 30 U.S. Sites
- San Francisco: Geneva Conference Review, July 22
source: AIDS Treatment News
